Selected research
Industry Research
High Sensitivity C‐Reactive Protein Test Industry Research Report 2026
Market perspective
The global High Sensitivity C‐Reactive Protein Test market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for High Sensitivity C‐Reactive Protein Test is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for High Sensitivity C‐Reactive Protein Test is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for High Sensitivity C‐Reactive Protein Test is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of High Sensitivity C‐Reactive Protein Test include Roche, Kehua Group, Beijing Strong Biotechnologies, Wondfo, Spinreact, Siemens Healthcare, Randox Laboratories, Ortho Clinical Diagnostics and Leadman Biochemistry, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global High Sensitivity C‐Reactive Protein Test market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
High Sensitivity C‐Reactive Protein Test Market by Company
Roche
Kehua Group
Beijing Strong Biotechnologies
Wondfo
Spinreact
Siemens Healthcare
Randox Laboratories
Ortho Clinical Diagnostics
Leadman Biochemistry
KANTO CHEMICAL
Getein Biotech
FUJIFILM
Boditech
BioSino
Beckman Coulter
High Sensitivity C‐Reactive Protein Test Segment by Type
Range 3-10mg/L
Range<3mg/L
High Sensitivity C‐Reactive Protein Test Segment by Application
Cardiovascular Disease
Inflammation
High Sensitivity C‐Reactive Protein Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global High Sensitivity C‐Reactive Protein Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of High Sensitivity C‐Reactive Protein Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of High Sensitivity C‐Reactive Protein Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of High Sensitivity C‐Reactive Protein Test manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of High Sensitivity C‐Reactive Protein Test by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of High Sensitivity C‐Reactive Protein Test in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Range 3-10mg/L
- Range<3mg/L
Applications
- Cardiovascular Disease
- Inflammation
Companies covered
- Roche
- Kehua Group
- Beijing Strong Biotechnologies
- Wondfo
- Spinreact
- Siemens Healthcare
- Randox Laboratories
- Ortho Clinical Diagnostics
- Leadman Biochemistry
- KANTO CHEMICAL
- Getein Biotech
- FUJIFILM
- Boditech
- BioSino
- Beckman Coulter
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global High Sensitivity C‐Reactive Protein Test Market Size (2021-2032)
- 2.2.2 Global High Sensitivity C‐Reactive Protein Test Sales (2021-2032)
- 2.2.3 Global High Sensitivity C‐Reactive Protein Test Market Average Price (2021-2032)
- 2.3 High Sensitivity C‐Reactive Protein Test by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Range 3-10mg/L
- 2.3.3 Range<3mg/L
- 2.4 High Sensitivity C‐Reactive Protein Test by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cardiovascular Disease
- 2.4.3 Inflammation
3 Market Competitive Landscape by Manufacturers
- 3.1 Global High Sensitivity C‐Reactive Protein Test Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global High Sensitivity C‐Reactive Protein Test Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global High Sensitivity C‐Reactive Protein Test Revenue of Manufacturers (2021-2026)
- 3.4 Global High Sensitivity C‐Reactive Protein Test Average Price by Manufacturers (2021-2026)
- 3.5 Global High Sensitivity C‐Reactive Protein Test Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of High Sensitivity C‐Reactive Protein Test, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of High Sensitivity C‐Reactive Protein Test, Product Type & Application
- 3.8 Global Manufacturers of High Sensitivity C‐Reactive Protein Test, Established Date
- 3.9 Global High Sensitivity C‐Reactive Protein Test Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Roche
- 4.1.1 Roche Company Information
- 4.1.2 Roche Business Overview
- 4.1.3 Roche High Sensitivity C‐Reactive Protein Test Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Roche High Sensitivity C‐Reactive Protein Test Product Portfolio
- 4.1.5 Roche Recent Developments
- 4.2 Kehua Group
- 4.2.1 Kehua Group Company Information
- 4.2.2 Kehua Group Business Overview
- 4.2.3 Kehua Group High Sensitivity C‐Reactive Protein Test Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Kehua Group High Sensitivity C‐Reactive Protein Test Product Portfolio
- 4.2.5 Kehua Group Recent Developments
- 4.3 Beijing Strong Biotechnologies
- 4.3.1 Beijing Strong Biotechnologies Company Information
- 4.3.2 Beijing Strong Biotechnologies Business Overview
- 4.3.3 Beijing Strong Biotechnologies High Sensitivity C‐Reactive Protein Test Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Beijing Strong Biotechnologies High Sensitivity C‐Reactive Protein Test Product Portfolio
- 4.3.5 Beijing Strong Biotechnologies Recent Developments
- 4.4 Wondfo
- 4.4.1 Wondfo Company Information
- 4.4.2 Wondfo Business Overview
- 4.4.3 Wondfo High Sensitivity C‐Reactive Protein Test Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Wondfo High Sensitivity C‐Reactive Protein Test Product Portfolio
- 4.4.5 Wondfo Recent Developments
- 4.5 Spinreact
- 4.5.1 Spinreact Company Information
- 4.5.2 Spinreact Business Overview
- 4.5.3 Spinreact High Sensitivity C‐Reactive Protein Test Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Spinreact High Sensitivity C‐Reactive Protein Test Product Portfolio
- 4.5.5 Spinreact Recent Developments
- 4.6 Siemens Healthcare
- 4.6.1 Siemens Healthcare Company Information
- 4.6.2 Siemens Healthcare Business Overview
- 4.6.3 Siemens Healthcare High Sensitivity C‐Reactive Protein Test Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Siemens Healthcare High Sensitivity C‐Reactive Protein Test Product Portfolio
- 4.6.5 Siemens Healthcare Recent Developments
- 4.7 Randox Laboratories
- 4.7.1 Randox Laboratories Company Information
- 4.7.2 Randox Laboratories Business Overview
- 4.7.3 Randox Laboratories High Sensitivity C‐Reactive Protein Test Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Randox Laboratories High Sensitivity C‐Reactive Protein Test Product Portfolio
- 4.7.5 Randox Laboratories Recent Developments
- 4.8 Ortho Clinical Diagnostics
- 4.8.1 Ortho Clinical Diagnostics Company Information
- 4.8.2 Ortho Clinical Diagnostics Business Overview
- 4.8.3 Ortho Clinical Diagnostics High Sensitivity C‐Reactive Protein Test Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ortho Clinical Diagnostics High Sensitivity C‐Reactive Protein Test Product Portfolio
- 4.8.5 Ortho Clinical Diagnostics Recent Developments
- 4.9 Leadman Biochemistry
- 4.9.1 Leadman Biochemistry Company Information
- 4.9.2 Leadman Biochemistry Business Overview
- 4.9.3 Leadman Biochemistry High Sensitivity C‐Reactive Protein Test Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Leadman Biochemistry High Sensitivity C‐Reactive Protein Test Product Portfolio
- 4.9.5 Leadman Biochemistry Recent Developments
- 4.10 KANTO CHEMICAL
- 4.10.1 KANTO CHEMICAL Company Information
- 4.10.2 KANTO CHEMICAL Business Overview
- 4.10.3 KANTO CHEMICAL High Sensitivity C‐Reactive Protein Test Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 KANTO CHEMICAL High Sensitivity C‐Reactive Protein Test Product Portfolio
- 4.10.5 KANTO CHEMICAL Recent Developments
- 4.11 Getein Biotech
- 4.11.1 Getein Biotech Company Information
- 4.11.2 Getein Biotech Business Overview
- 4.11.3 Getein Biotech High Sensitivity C‐Reactive Protein Test Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Getein Biotech High Sensitivity C‐Reactive Protein Test Product Portfolio
- 4.11.5 Getein Biotech Recent Developments
- 4.12 FUJIFILM
- 4.12.1 FUJIFILM Company Information
- 4.12.2 FUJIFILM Business Overview
- 4.12.3 FUJIFILM High Sensitivity C‐Reactive Protein Test Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 FUJIFILM High Sensitivity C‐Reactive Protein Test Product Portfolio
- 4.12.5 FUJIFILM Recent Developments
- 4.13 Boditech
- 4.13.1 Boditech Company Information
- 4.13.2 Boditech Business Overview
- 4.13.3 Boditech High Sensitivity C‐Reactive Protein Test Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Boditech High Sensitivity C‐Reactive Protein Test Product Portfolio
- 4.13.5 Boditech Recent Developments
- 4.14 BioSino
- 4.14.1 BioSino Company Information
- 4.14.2 BioSino Business Overview
- 4.14.3 BioSino High Sensitivity C‐Reactive Protein Test Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 BioSino High Sensitivity C‐Reactive Protein Test Product Portfolio
- 4.14.5 BioSino Recent Developments
- 4.15 Beckman Coulter
- 4.15.1 Beckman Coulter Company Information
- 4.15.2 Beckman Coulter Business Overview
- 4.15.3 Beckman Coulter High Sensitivity C‐Reactive Protein Test Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Beckman Coulter High Sensitivity C‐Reactive Protein Test Product Portfolio
- 4.15.5 Beckman Coulter Recent Developments
5 Global High Sensitivity C‐Reactive Protein Test Market Scenario by Region
- 5.1 Global High Sensitivity C‐Reactive Protein Test Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global High Sensitivity C‐Reactive Protein Test Sales by Region: 2021-2032
- 5.2.1 Global High Sensitivity C‐Reactive Protein Test Sales by Region: 2021-2026
- 5.2.2 Global High Sensitivity C‐Reactive Protein Test Sales by Region: 2027-2032
- 5.3 Global High Sensitivity C‐Reactive Protein Test Revenue by Region: 2021-2032
- 5.3.1 Global High Sensitivity C‐Reactive Protein Test Revenue by Region: 2021-2026
- 5.3.2 Global High Sensitivity C‐Reactive Protein Test Revenue by Region: 2027-2032
- 5.4 North America High Sensitivity C‐Reactive Protein Test Market Facts & Figures by Country
- 5.4.1 North America High Sensitivity C‐Reactive Protein Test Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America High Sensitivity C‐Reactive Protein Test Sales by Country (2021-2032)
- 5.4.3 North America High Sensitivity C‐Reactive Protein Test Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe High Sensitivity C‐Reactive Protein Test Market Facts & Figures by Country
- 5.5.1 Europe High Sensitivity C‐Reactive Protein Test Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe High Sensitivity C‐Reactive Protein Test Sales by Country (2021-2032)
- 5.5.3 Europe High Sensitivity C‐Reactive Protein Test Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific High Sensitivity C‐Reactive Protein Test Market Facts & Figures by Country
- 5.6.1 Asia Pacific High Sensitivity C‐Reactive Protein Test Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific High Sensitivity C‐Reactive Protein Test Sales by Country (2021-2032)
- 5.6.3 Asia Pacific High Sensitivity C‐Reactive Protein Test Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America High Sensitivity C‐Reactive Protein Test Market Facts & Figures by Country
- 5.7.1 South America High Sensitivity C‐Reactive Protein Test Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America High Sensitivity C‐Reactive Protein Test Sales by Country (2021-2032)
- 5.7.3 South America High Sensitivity C‐Reactive Protein Test Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa High Sensitivity C‐Reactive Protein Test Market Facts & Figures by Country
- 5.8.1 Middle East and Africa High Sensitivity C‐Reactive Protein Test Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa High Sensitivity C‐Reactive Protein Test Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa High Sensitivity C‐Reactive Protein Test Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global High Sensitivity C‐Reactive Protein Test Sales by Type (2021-2032)
- 6.1.1 Global High Sensitivity C‐Reactive Protein Test Sales by Type (2021-2032) & (k units)
- 6.1.2 Global High Sensitivity C‐Reactive Protein Test Sales Market Share by Type (2021-2032)
- 6.2 Global High Sensitivity C‐Reactive Protein Test Revenue by Type (2021-2032)
- 6.2.1 Global High Sensitivity C‐Reactive Protein Test Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global High Sensitivity C‐Reactive Protein Test Revenue Market Share by Type (2021-2032)
- 6.3 Global High Sensitivity C‐Reactive Protein Test Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global High Sensitivity C‐Reactive Protein Test Sales by Application (2021-2032)
- 7.1.1 Global High Sensitivity C‐Reactive Protein Test Sales by Application (2021-2032) & (k units)
- 7.1.2 Global High Sensitivity C‐Reactive Protein Test Sales Market Share by Application (2021-2032)
- 7.2 Global High Sensitivity C‐Reactive Protein Test Revenue by Application (2021-2032)
- 7.2.1 Global High Sensitivity C‐Reactive Protein Test Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global High Sensitivity C‐Reactive Protein Test Revenue Market Share by Application (2021-2032)
- 7.3 Global High Sensitivity C‐Reactive Protein Test Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 High Sensitivity C‐Reactive Protein Test Value Chain Analysis
- 8.1.1 High Sensitivity C‐Reactive Protein Test Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 High Sensitivity C‐Reactive Protein Test Production Mode & Process
- 8.2 High Sensitivity C‐Reactive Protein Test Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 High Sensitivity C‐Reactive Protein Test Distributors
- 8.2.3 High Sensitivity C‐Reactive Protein Test Customers
9 Global High Sensitivity C‐Reactive Protein Test Analyzing Market Dynamics
- 9.1 High Sensitivity C‐Reactive Protein Test Industry Trends
- 9.2 High Sensitivity C‐Reactive Protein Test Industry Drivers
- 9.3 High Sensitivity C‐Reactive Protein Test Industry Opportunities and Challenges
- 9.4 High Sensitivity C‐Reactive Protein Test Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst